Sepracor Shares Rise on Insomnia Drug OK
642470
Drug maker Sepracor Inc. has won federal approval for a prescription insomnia medication the company is counting on to challenge larger rivals in the fast-growing $2.1 billion-a-year sleep aid market.
326531
Alpharma Inc. ALO.N on Friday said a  federal appellate court has set aside its earlier order that  had prevented the company from launching a generic form of  Pfizer Inc's PFE.N Neurontin capsules to treat epilepsy,  sending Alpharma shares higher.
505962
Cephalon gets some good news about its drug PROVIGIL.
237168
Shares of Nastech Pharmaceutical Co.  Inc. NSTK.O jumped 23 percent before the bell on Monday after  the company said it tied up with Merck & Co. MRK.N to develop  and market Nastech's experimental nasal spray treatment for  obesity.
753248
Shares of CoTherix Inc. shot up 30 percent to a new 52-week high Thursday following the Food and Drug Administration&#39;s approval of its lead product candidate, an inhaled treatment for high blood pressure in the arteries of the lungs.
658531
A federal appeals court has cleared  the way for Alpharma Inc. ALO.N to launch a generic form of  Pfizer Inc.'s PFE.N Neurontin capsules to treat epilepsy,  sending Alpharma shares sharply higher.
212798
NEW YORK, December 16  - Specialty pharmaceutical company Sepracor (SEPR.NAS) announced yesterday that it had received the FDA approval for marketing its Lunesta treatment for insomnia.
102028
Sanofi-Aventis  posted higher than expected fourth-quarter profits on Tuesday and predicted more growth for 2007, but a further delay in its key new anti-obesity drug Acomplia hit the shares.
634298
Shares of Biocryst Pharmaceuticals Inc. (BCRX.O) rose on Tuesday after the company received "orphan drug" status for an anti-cancer compound.
294745
People who suffer from insomnia can rest easier now with the approval of a new sleeping pill by Sepracor, called Lunesta. The drug, which can be taken without time restrictions offers a good night&#39;s sleep
478980
Shares of German drugmaker Merck KGaA climbed sharply Tuesday after the company released successful new study results for its cancer drug Erbitux. Shares of biotechnology company ImClone, which developed the drug, soared nearly 24 percent in the U.S.
260235
U.S. stocks nudged higher on Tuesday,  helped by a jump in drug maker Pfizer Inc. PFE.N, while gains  in semiconductor shares helped support the tech-dominated  Nasdaq index.
652440
The FTSE 100 has climbed as a surge by US shares gives a boost to European markets. Shire Pharmaceuticals SHP.L jumped after winning approval for a key drug and consumer goods giant Unilever ULVR.
560144
U.S. stocks traded higher on  Wednesday, with shares of drugmaker Merck & Co. MRK.N helping  to boost the Dow after its 2005 forecast offered relief to some  investors on Wall Street.
747914
Shares of Cotherix Inc. leaped Thursday, after the US Food and Drug Administration approved its inhalant for patients with most types of pulmonary arterial hypertension, or PAH.
323850
Shares in Reuters Group PLC rose Thursday on speculation that its part-owned stock-trading network Instinet Group Inc. is up for sale.
349051
Shares of drugmaker Merck & Co. Inc.  traded 1.52 percent higher on volume of more than 61,000 shares in pre-market dealings on Friday, a day after the stock plunged to an eight-year low after the company withdrew its arthritis drug Vioxx.